Inari Medical, Inc. Common Stock
NARI
NARI was delisted on the 18th of February, 2025.
152 hedge funds and large institutions have $1.74B invested in Inari Medical, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 55 increasing their positions, 17 reducing their positions, and 16 closing their positions.
331% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 16
224% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 17
188% more capital invested
Capital invested by funds: $604M → $1.74B (+$1.14B)
54% more funds holding
Funds holding: 99 → 152 (+53)
8% less call options, than puts
Call options by funds: $7.37M | Put options by funds: $7.99M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VVM
Versant Venture Management
San Francisco,
California
|
+$162M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$63.5M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$57.8M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$54.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$50.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$12.7M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$4.75M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
-$3.45M |
| 4 |
CCM
CAAS Capital Management
New York
|
-$2.07M |
| 5 |
LCG
Lisanti Capital Growth
New York
|
-$1.92M |
NARI Hedge Fund Activity: Q4 2020 in Review
152 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q4 2020, worth a combined $1.74B — up 188% from $604M a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new NARI positions and 16 closed out — a net gain of 53 holders — while 55 added to existing stakes and 17 trimmed.
The largest buyer was Versant Venture Management, opening a new position worth an estimated $162M. The largest seller was Perceptive Advisors, cutting an estimated $12.7M.
- 152 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q4 2020, up from 99 in Q3 2020.
- Funds reported $1.74B of Inari Medical, Inc. Common Stock stock for Q4 2020, up 188% quarter-over-quarter.
- 69 funds opened new Inari Medical, Inc. Common Stock positions in Q4 2020 and 16 closed out, a net change of +53 holders.
- The largest Inari Medical, Inc. Common Stock buyer in Q4 2020 was Versant Venture Management, an estimated $162M added.
- The largest Inari Medical, Inc. Common Stock seller in Q4 2020 was Perceptive Advisors, an estimated $12.7M sold.
Based on aggregated 13F filings for Q4 2020.